Heme oxygenase‐1 attenuates the inhibitory effect of bortezomib against the APRIL‐NF‐κB‐CCL3 signaling pathways in multiple myeloma cells: Corelated with bortezomib tolerance in multiple myeloma.

Published in:

Journal of Cellular Biochemistry, 2019, v. 120, n. 5, p. 6972, doi. 10.1002/jcb.27879

By:

• He, Zheng C.;
• Li, Xin Y.;
• Guo, Yong L.;
• Ma, Dan;
• Fang, Qin;
• Ren, Ling L.;
• Zhang, Zhao Y.;
• Wang, Weili;
• Yu, Zheng Y.;
• Zhao, Peng;
• Wang, Ji S.

Publication type:

Article